{{Rsnum
|rsid=1256062
|Gene=ESR2
|Chromosome=14
|position=64236600
|Orientation=minus
|GMAF=0.2727
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ESR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.3 | 23.0 | 2.7
| HCB | 35.8 | 47.4 | 16.8
| JPT | 38.9 | 46.9 | 14.2
| YRI | 29.9 | 46.9 | 23.1
| ASW | 40.4 | 45.6 | 14.0
| CHB | 35.8 | 47.4 | 16.8
| CHD | 29.4 | 52.3 | 18.3
| GIH | 58.4 | 34.7 | 6.9
| LWK | 33.6 | 54.5 | 11.8
| MEX | 81.0 | 15.5 | 3.4
| MKK | 35.3 | 47.4 | 17.3
| TSI | 63.7 | 33.3 | 2.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1256062
|Name_s=ESR2:rs1256062
|Gene_s=ESR2
|Feature=
|Evidence=PubMed ID:17579196
|Annotation=Haplotype tagging SNP.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161145073
}}

{{PMID Auto
|PMID=16551880
|Title=Estrogen receptor beta polymorphism is associated with prostate cancer risk.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1256062
|overall_frequency_n=38
|overall_frequency_d=128
|overall_frequency=0.296875
|n_genomes=24
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24326520
|Title=Estrogen Receptor β Variants Modify Risk for Alzheimer's Disease in a Multiethnic Female Cohort
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}